Concepedia

Author

Hailong Tang

Xijing HospitalORCID

Also Known As

H Tang, H. Tang, Hai-Long Tang, HaiLong TANG, Hailong Tang, Haodan Tang, Haoyuan TANG, Tang H, Tang, Hailong

40

Publications

691

Citations

12

H-Index

38

Concepts

All Affiliations

Xijing HospitalAir Force Medical UniversityNorthwest University
HT

About

Hailong Tang is an author at Xijing Hospital specializing in medicine, tumor biology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

164

2

Cell Biology

4

4

62

3

Immunology

2

2

31

4

Health Sciences

1

1

58

5

Hepatology

1

1

58

Hailong Tang

×

12

Publications

584

Citations

11

H-Index

YearCitations

A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide

Jie Sun, David N. Fass, Margaret A. Viss,

Clinical & Experimental Immunology

1998

354

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma

Hui Xie, Jae Yun Song, Rui Du,

Digestive and Liver Disease

2006

58

Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution

Chun Cao, Juan Feng, Hongtao Gu,

Annals of Diagnostic Pathology

2017

24

PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer

Ping Gao, Jinglan Hao, Qianwen Xie,

Oncogene

2022

24

The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects

Hong-Yuan Shen, Hailong Tang, Yanhua Zheng,

Journal of Oncology

2022

22

Chidamide epigenetically represses autophagy and exerts cooperative antimyeloma activity with bortezomib

Li Xu, Juan Feng, Hailong Tang,

Cell Death and Disease

2020

21

Invasive fungal infection caused by geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review.

Guangxun Gao, Hailong Tang, Xuan Zhang,

PubMed

2015

20

Pharmacological inhibition of EZH2 combined with DNA‑damaging agents interferes with the DNA damage response in MM cells

Li Xu, Hailong Tang, Kai Wang,

Molecular Medicine Reports

2019

15

BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib <i>in vitro</i> and <i>in vivo</i> by promoting mitochondrial pathway-mediated cell apoptosis

Guang Li, Yanhua Zheng, Li Xu,

Therapeutic Advances in Hematology

2020

13

Low dose dinaciclib enhances doxorubicin‑induced senescence in myeloma RPMI8226 cells by transformation of the p21 and p16 pathways

Hailong Tang, Li Xu, Xue Liang,

Oncology Letters

2018

12

Page 1